中文名 | 3-异丁基-1-甲基黄嘌呤 |
英文名 | 3,7-dihydro-3-isobutyl-1-methyl-1H-purine-2,6-dione |
别名 | 3-异丁基-1-甲基黄嘌呤 3-异丁基-1-甲基黄嘌呤(IBMX) 3-异丁基-1-甲基-2,6(1H,3H)-嘌呤二酮 3-异丁基-1-甲基-1H-嘌呤-2,6(3H,9H)-二酮 3-异丁基-1-甲基-3,9-二氢-1H-嘌呤-2,6-二酮 3-ISOBUTYL-1-METHYLXANTHINE 3-异丁基-1-甲基黄嘌呤 IBMX |
英文别名 | IMX Isobutylmethylxanthine Methylisobutylxanthine 3-isobutyl-1-methyl-xanthin 3-Isobutyl-1-methylanxthine 3,7-dihydro-3-isobutyl-1-methyl-1H-purine-2,6-dione 3-Isobutyl-1-methyl-3,7-dihydro-1H-purine-2,6-dione 3,7-dihydro-1-methyl-3-(2-methylpropyl)-1h-purine-6-dione 1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)- |
CAS | 28822-58-4 |
EINECS | 249-259-3 |
化学式 | C10H14N4O2 |
分子量 | 222.24 |
InChI | InChI=1/C10H14N4O2/c1-6(2)4-14-8-7(11-5-12-8)9(15)13(3)10(14)16/h5-6H,4H2,1-3H3,(H,11,12) |
InChIKey | APIXJSLKIYYUKG-UHFFFAOYSA-N |
密度 | 1.2042 (rough estimate) |
熔点 | 200-201°C(lit.) |
沸点 | 363.42°C (rough estimate) |
闪点 | 223.3°C |
蒸汽压 | 3.89E-08mmHg at 25°C |
溶解度 | DMSO: 1m,温和升温 |
折射率 | 1.6500 (estimate) |
酸度系数 | 8.61±0.70(Predicted) |
存储条件 | -20°C |
稳定性 | 从提供的购买之日起稳定2年。DMSO或乙醇中的溶液可以在-20 °C下储存长达3个月。 |
外观 | 粉末 |
颜色 | off-white |
BRN | 247859 |
MDL号 | MFCD00005584 |
体外研究 | At 100 μM, KMUP-1 (a xanthine derivative) and IBMX are the most effective at inducing tracheal relaxation; the magnitude of the relaxation responses induced by KMUP-1 and IBMX are not significantly different. IBMX (100 μM) activates renal outer medullary K + (ROMK) channels (n=6, P<0.05) and prevents further channel activation by ANG II (n=6, P=NS) or cGMP. Of note is that pretreatment of cortical collecting duct (CCDs) isolated from high-K + (HK)-fed rats with IBMX (100 μM) for 20 min leads to a significant increase in tubular cAMP content to 1.43±0.35 pg/mm tubule length (n=14) compare with that measured in vehicle-treated controls (0.61±0.13 pg/mm tubule length, n=12, P<0.05). |
体内研究 | IBMX, a non-selective PDE inhibitor significantly decreases the liver glycogen storage (mg/g, IBMX 22±1.5 P<0.001). In comparison with the control group, IBMX and mc5 significantly increase plasma glucose (blood glucose, mg/dl, control=141±3, IBMX=210±17 P<0.001 and mc5=191±13 P<0.01) while other test compounds (mc1, mc6, MCPIP and Win 47203) do not produce significant effect (control=141±3, mc1 160±7, mc6 175±9, MCPIP 179±8 and Win 47203 116±2 P>0.05) also mc2 does not change plasma glucose (control=141±3 and mc2=145±5). IBMX has the highest efficacy on increasing plasma glucose. Treatments with IBMX and Apocynin significantly decrease cold-induced elevation of right ventricular (RV) systolic pressure (23.5±1.8 and 24.2±0.6 mmHg, respectively) although they do not decrease RV pressure to the warm control levels. IBMX or Apocynin significantly reduces medial layer thickness (19.0±0.9, and 16.9±0.8 μm, respectively) and increases lumen diameter (62.7±4.2, and 59.5±4.3 μm, respectively) of small PAs in cold-exposed rats. |
危险品标志 | Xn - 有害物品 |
风险术语 | 22 - 吞食有害。 |
安全术语 | 24/25 - 避免与皮肤和眼睛接触。 |
WGK Germany | 3 |
RTECS | ZD8500000 |
海关编号 | 29335990 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!